FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034790774> ?p ?o ?g. }

• W2034790774 endingPage "106" @default.
• W2034790774 startingPage "90" @default.
• W2034790774 abstract "Purpose: Gemcitabine and capecitabine (gem-cap), gemcitabine and erlotinib (gem-e), and folfirinox (5-fluorouracil–leucovorin–irinotecan–oxaliplatin) are new treatment options for metastatic pancreatic cancer, but they are also more expensive and potentially more toxic than gemcitabine alone (gem). We conducted a cost-effectiveness analysis of these treatment options compared with gem. Methods: A Markov model was constructed to examine costs and outcomes of gem-cap, gem-e, folfirinox, and gem in patients with metastatic pancreatic cancer from the perspective of a government health care plan. Ontario health economic and costing data (2010 Canadian dollars) were used. Efficacy data for the treatments were obtained from the published literature. Resource utilization data were derived from a chart review of consecutive metastatic patients treated for pancreatic cancer at Princess Margaret Hospital, Toronto, Ontario, 2008–2009, and supplemented with data from the literature. Utilities were obtained by surveying medical oncologists across Canada using the EQ-5D. Incremental cost-effectiveness ratios (icers) were calculated. Results: The icers for gem-cap, gem-e, and folfirinox compared with gem were, respectively, CA$84,299, CA$153,631, and CA$133,184 per quality-adjusted life year (qaly). The model was driven mostly by drug acquisition costs. Given a willingness-to-pay (wtp) threshold greater than CA$130,000/qaly, folfirinox was most cost-effective treatment. When the wtp threshold was less than CA$80,000/qaly, gem alone was most cost-effective. The gem-e option was dominated by the other treatments. Conclusions: The most cost-effective treatment for metastatic pancreatic cancer depends on the societal wtp threshold. If the societal wtp threshold were to be relatively high or if drug costs were to be substantially reduced, folfirinox might be cost-effective." @default.
• W2034790774 created "2016-06-24" @default.
• W2034790774 creator A5008282524 @default.
• W2034790774 creator A5012549313 @default.
• W2034790774 creator A5018567739 @default.
• W2034790774 creator A5024269299 @default.
• W2034790774 creator A5079676031 @default.
• W2034790774 creator A5080776657 @default.
• W2034790774 creator A5089962672 @default.
• W2034790774 date "2013-04-01" @default.
• W2034790774 modified "2023-09-27" @default.
• W2034790774 title "Cost-Effectiveness of Systemic Therapies for Metastatic Pancreatic Cancer" @default.
• W2034790774 cites W1859092351 @default.
• W2034790774 cites W1931508686 @default.
• W2034790774 cites W1965542961 @default.
• W2034790774 cites W1971245874 @default.
• W2034790774 cites W1974922522 @default.
• W2034790774 cites W1991414891 @default.
• W2034790774 cites W1992911625 @default.
• W2034790774 cites W2073455467 @default.
• W2034790774 cites W2076728105 @default.
• W2034790774 cites W2083452953 @default.
• W2034790774 cites W2101713088 @default.
• W2034790774 cites W2110701556 @default.
• W2034790774 cites W2113566724 @default.
• W2034790774 cites W2117105709 @default.
• W2034790774 cites W2128095147 @default.
• W2034790774 cites W2144025124 @default.
• W2034790774 cites W2151253787 @default.
• W2034790774 cites W2158134441 @default.
• W2034790774 cites W2397947918 @default.
• W2034790774 cites W2589733809 @default.
• W2034790774 doi "https://doi.org/10.3747/co.20.1223" @default.
• W2034790774 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3615875" @default.
• W2034790774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23559890" @default.
• W2034790774 hasPublicationYear "2013" @default.
• W2034790774 type Work @default.
• W2034790774 sameAs 2034790774 @default.
• W2034790774 citedByCount "54" @default.
• W2034790774 countsByYear W20347907742013 @default.
• W2034790774 countsByYear W20347907742014 @default.
• W2034790774 countsByYear W20347907742015 @default.
• W2034790774 countsByYear W20347907742016 @default.
• W2034790774 countsByYear W20347907742017 @default.
• W2034790774 countsByYear W20347907742018 @default.
• W2034790774 countsByYear W20347907742019 @default.
• W2034790774 countsByYear W20347907742020 @default.
• W2034790774 countsByYear W20347907742021 @default.
• W2034790774 countsByYear W20347907742022 @default.
• W2034790774 countsByYear W20347907742023 @default.
• W2034790774 crossrefType "journal-article" @default.
• W2034790774 hasAuthorship W2034790774A5008282524 @default.
• W2034790774 hasAuthorship W2034790774A5012549313 @default.
• W2034790774 hasAuthorship W2034790774A5018567739 @default.
• W2034790774 hasAuthorship W2034790774A5024269299 @default.
• W2034790774 hasAuthorship W2034790774A5079676031 @default.
• W2034790774 hasAuthorship W2034790774A5080776657 @default.
• W2034790774 hasAuthorship W2034790774A5089962672 @default.
• W2034790774 hasBestOaLocation W20347907741 @default.
• W2034790774 hasConcept C112930515 @default.
• W2034790774 hasConcept C121608353 @default.
• W2034790774 hasConcept C126322002 @default.
• W2034790774 hasConcept C143998085 @default.
• W2034790774 hasConcept C2777148230 @default.
• W2034790774 hasConcept C2777909004 @default.
• W2034790774 hasConcept C2778087573 @default.
• W2034790774 hasConcept C2779438470 @default.
• W2034790774 hasConcept C2779900020 @default.
• W2034790774 hasConcept C2780210213 @default.
• W2034790774 hasConcept C2780258809 @default.
• W2034790774 hasConcept C2780259306 @default.
• W2034790774 hasConcept C2780962732 @default.
• W2034790774 hasConcept C3019080777 @default.
• W2034790774 hasConcept C526805850 @default.
• W2034790774 hasConcept C64332521 @default.
• W2034790774 hasConcept C71924100 @default.
• W2034790774 hasConceptScore W2034790774C112930515 @default.
• W2034790774 hasConceptScore W2034790774C121608353 @default.
• W2034790774 hasConceptScore W2034790774C126322002 @default.
• W2034790774 hasConceptScore W2034790774C143998085 @default.
• W2034790774 hasConceptScore W2034790774C2777148230 @default.
• W2034790774 hasConceptScore W2034790774C2777909004 @default.
• W2034790774 hasConceptScore W2034790774C2778087573 @default.
• W2034790774 hasConceptScore W2034790774C2779438470 @default.
• W2034790774 hasConceptScore W2034790774C2779900020 @default.
• W2034790774 hasConceptScore W2034790774C2780210213 @default.
• W2034790774 hasConceptScore W2034790774C2780258809 @default.
• W2034790774 hasConceptScore W2034790774C2780259306 @default.
• W2034790774 hasConceptScore W2034790774C2780962732 @default.
• W2034790774 hasConceptScore W2034790774C3019080777 @default.
• W2034790774 hasConceptScore W2034790774C526805850 @default.
• W2034790774 hasConceptScore W2034790774C64332521 @default.
• W2034790774 hasConceptScore W2034790774C71924100 @default.
• W2034790774 hasIssue "2" @default.
• W2034790774 hasLocation W20347907741 @default.
• W2034790774 hasLocation W20347907742 @default.
• W2034790774 hasLocation W20347907743 @default.
• W2034790774 hasLocation W20347907744 @default.

• next